Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Kovaltry (Anti-haemophilic Factor VII (Recombinant)) for the Treatment of Haemophilia A

Drug (Brand/Generic)

Kovaltry (Anti-haemophilic Factor VII (Recombinant))

Company

Bayer

Therapy Class

Anti-haemorrhagic

Current Indication

Haemophilia A

Development Status

Approved in US, Europe and Canada
Expand

Go Top